Status:
COMPLETED
Advanced Modeling of the Evolution of the Epidemiological Outbreak of SARS-CoV-2 Pandemic
Lead Sponsor:
Hospital Galdakao-Usansolo
Collaborating Sponsors:
Basque Government Department of Public Health
University of the Basque Country (UPV/EHU)
Conditions:
COVID-19
Eligibility:
All Genders
Brief Summary
The various epidemics that health systems periodically suffers require having valid and detailed information on its evolution and predictions in the short, medium and long term in real time to allow t...
Detailed Description
Design. Retrospective observational study. The modeling will be based on the SARS-CoV-2 pandemic that started at the beginning of 2020. Subjects of the study. Information will be collected on daily i...
Eligibility Criteria
Inclusion
- To be a positive SARS-CoV-2 infection laboratory-confirmed by a positive result on the reverse transcriptase-polymerase chain reaction assay for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) or a positive antigen test from March 1, 2020 to January 9, 2022
- For hospital admissions:
- Consider different episodes as a single admission when it comes to transfers from one center to another.
- Exclusively admissions due to COVID-19.
Exclusion
- • Patients admitted for other reasons who have developed the disease during their hospital stay.
Key Trial Info
Start Date :
March 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2023
Estimated Enrollment :
715206 Patients enrolled
Trial Details
Trial ID
NCT06070896
Start Date
March 1 2020
End Date
December 31 2023
Last Update
February 28 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Galdakao-Usansolo
Galdakao, Bizkaia, Spain, 48960